Accessibility Statement

Our commitment

Affector is committed to making its content and services accessible to everyone, including people with disabilities. We follow the Web Content Accessibility Guidelines (WCAG) 2.1 at Level AA and align with the European Accessibility Act (Directive (EU) 2019/882).

Conformance status

This website partially conforms to WCAG 2.1 Level AA. The exceptions listed below prevent a fully conformant rating; we are working to reduce or eliminate them over time.

Assessment methodology

This statement is based on a self-evaluation that combines automated testing (axe-core and Lighthouse) with manual testing carried out using keyboard navigation and the NVDA screen reader on recent versions of Chrome, Firefox and Safari.

Statement last reviewed on 19 April 2026.

Known exceptions

The following content or features may not yet fully meet WCAG 2.1 Level AA:

  • Embedded video may not include captions or audio descriptions.
  • PDF documents available for download have not been validated against PDF/UA.
  • Third-party content embedded via iframes (for example, social media embeds) is outside our direct control and may not meet WCAG 2.1 Level AA.
  • The private editorial interface used by our editors is not a public-facing service and is outside the scope of this statement.

Feedback and reporting a barrier

We welcome feedback on the accessibility of our service. If you encounter a barrier, please let us know and include the page URL, the nature of the issue and, if possible, the assistive technology you use. We aim to respond within 30 days.

Contact: office@codeenable.com

Supervisory authority

If you are not satisfied with our response, you may contact the competent national accessibility authority in your country. In Poland, this is the Commissioner for Human Rights (Rzecznik Praw Obywatelskich).

Made by

Affector by Codeenable

Affector is an editorial publication run by Codeenable, a software studio. We publish two parallel beats: one on pharmaceuticals, medicine, biology and life sciences; one on software, its architecture, AI and cloud. We chose this combination on purpose, not by accident.

About Contact

Affector writes about pharmaceuticals, medicine, biology and the life and human sciences, and also about the technical underpinnings that make these fields advance.

We publish across domains that touch both the core subjects, pharma and medicine, and the technical craft that supports them - software, its architecture, and the current dominance of cloud solutions and AI.

Both silos genuinely interest our team, and the need to integrate digital techniques into medicine, pharma and the human sciences is growing at an avalanche pace.

Without cooperation with software teams, real progress in medicine and pharma is hard to come by today, and the most ambitious engineering projects increasingly emerge in response to real problems in biology and the clinic.

Hence the long-form, sourced writing that does not flinch at code or at clinical detail, producing a unique combination that is genuinely useful to clinicians and engineers alike.